{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30151073", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "29"}], "Language": ["eng"], "ELocationID": ["7280342", "10.1155/2018/7280342"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2018", "PubDate": {"Year": "2018"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Protocatechuic Acid Attenuates Trabecular Bone Loss in Ovariectomized Mice.", "Pagination": {"StartPage": "7280342", "MedlinePgn": "7280342"}, "Abstract": {"AbstractText": ["Primary osteoporosis is a disease related to excessive bone resorption due to estrogen insufficiency that occurs postmenopause. Protocatechuic acid (PCA), or 3,4-dihydroxybenzoic acid, is a common compound present in numerous plants. Although numerous biological activities of PCA have been identified, its antiosteoporotic function has not been well established. In this study, the antiosteoporotic activity of PCA supplementation was determined in ovariectomized (OVX) female ICR mice at 12 weeks after OVX. The biomechanical properties of a bone were evaluated by microcomputed tomography. The signaling molecules associated with osteoclast differentiation were determined in bone marrow cells through immunoblot or RT-PCR. Oral supplementation with PCA (20\u2009mg/kg/day) significantly ameliorated the OVX-mediated stimulation of osteoclast activity based on decreases in serum levels of receptor activator of nuclear factor <i>\u03ba</i>B ligand (RANKL), osteocalcin, and bone alkaline phosphatase and increase in serum osteoprotegerin (each group, <i>n</i> = 6; <i>p</i> < 0.05). In addition, the OVX-induced decreases in mRNA expression levels of cathepsin K, calcitonin receptor, nuclear factor of activated T cell cytoplasmic 1 (NFATc1), and tumor necrosis factor (TNF) receptor-associated factor-6 (TRAF6) in bone marrow cells were significantly attenuated (each group, <i>n</i> = 6; <i>p</i> < 0.05). Finally, the loss of trabecular bone and changes in biomechanical properties of a bone were significantly improved by supplementation with 20\u2009mg/kg PCA (each group, <i>n</i> = 6; <i>p</i> < 0.05). Collectively, our results show that PCA supplement suppressed trabecular bone loss in OVX mice and therefore might be an effective alternative approach for preventing the progression of postmenopausal osteoporosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, Republic of Korea."}], "LastName": "Jang", "ForeName": "Seon-A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, Republic of Korea."}], "LastName": "Song", "ForeName": "Hae Seong", "Initials": "HS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, Republic of Korea."}], "LastName": "Kwon", "ForeName": "Jeong Eun", "Initials": "JE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, Republic of Korea."}], "LastName": "Baek", "ForeName": "Hyun Jin", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Industrial Crops, Korea National College of Agriculture and Fisheries, Jeonju 54874, Republic of Korea."}], "LastName": "Koo", "ForeName": "Hyun Jung", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Herbal Medicine Resources, Kangwon National University, Samcheok 25949, Republic of Korea."}], "LastName": "Sohn", "ForeName": "Eun-Hwa", "Initials": "EH"}, {"Identifier": ["0000-0002-6250-5149"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Convergence Biomedical Science, Cardiovascular and Metabolic Disease Center, College of Medicine, Inje University, Busan 47392, Republic of Korea."}], "LastName": "Lee", "ForeName": "Sung Ryul", "Initials": "SR"}, {"Identifier": ["0000-0003-0790-2237"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin 17104, Republic of Korea."}], "LastName": "Kang", "ForeName": "Se Chan", "Initials": "SC"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hydroxybenzoates"}, {"RegistryNumber": "36R5QJ8L4B", "NameOfSubstance": "protocatechuic acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pathology"], "DescriptorName": "Cancellous Bone"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hydroxybenzoates"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ovariectomy"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kakkar S., Bais S. A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacology. 2014;2014:9. doi: 10.1155/2014/952943.952943", "ArticleIdList": ["10.1155/2014/952943", "PMC4005030", "25006494"]}, {"Citation": "Semaming Y., Pannengpetch P., Chattipakorn S. C., Chattipakorn N. Pharmacological properties of protocatechuic acid and its potential roles as complementary medicine. Evidence-based Complementary and Alternative Medicine. 2015;2015:11. doi: 10.1155/2015/593902.593902", "ArticleIdList": ["10.1155/2015/593902", "PMC4337037", "25737736"]}, {"Citation": "Khan A. K., Rashid R., Fatima N., et al. Pharmacological activities of protocatechuic acid. Acta Poloniae Pharmaceutica. 2015;72(4):643\u2013650.", "ArticleIdList": ["26647619"]}, {"Citation": "Chen H., Kubo K. Y. Bone three-dimensional microstructural features of the common osteoporotic fracture sites. World Journal of Orthopedics. 2014;5(4):486\u2013495. doi: 10.5312/wjo.v5.i4.486.", "ArticleIdList": ["10.5312/wjo.v5.i4.486", "PMC4133454", "25232524"]}, {"Citation": "Vaananen H. K. Mechanism of bone turnover. Annals of Medicine. 1993;25(4):353\u2013359. doi: 10.3109/07853899309147297.", "ArticleIdList": ["10.3109/07853899309147297", "8217101"]}, {"Citation": "Seibel M. J. Biochemical markers of bone turnover: part I: biochemistry and variability. The Clinical Biochemist Reviews. 2005;26(4):97\u2013122.", "ArticleIdList": ["PMC1320175", "16648882"]}, {"Citation": "Bouxsein M. L. Mechanisms of osteoporosis therapy: a bone strength perspective. Clinical Cornerstone. 2003;5(Supplement 2):S13\u2013S21. doi: 10.1016/s1098-3597(03)90043-3.", "ArticleIdList": ["10.1016/s1098-3597(03)90043-3", "15035555"]}, {"Citation": "Nazarian A., von Stechow D., Zurakowski D., M\u00fcller R., Snyder B. D. Bone volume fraction explains the variation in strength and stiffness of cancellous bone affected by metastatic cancer and osteoporosis. Calcified Tissue International. 2008;83(6):368\u2013379. doi: 10.1007/s00223-008-9174-x.", "ArticleIdList": ["10.1007/s00223-008-9174-x", "18946628"]}, {"Citation": "Wilkins C. H. Osteoporosis screening and risk management. Clinical Interventions in Aging. 2007;2(3):389\u2013394.", "ArticleIdList": ["PMC2685263", "18044189"]}, {"Citation": "Lane N. E. Epidemiology, etiology, and diagnosis of osteoporosis. American Journal of Obstetrics and Gynecology. 2006;194(2):S3\u201311. doi: 10.1016/j.ajog.2005.08.047.", "ArticleIdList": ["10.1016/j.ajog.2005.08.047", "16448873"]}, {"Citation": "Josse R. G. Osteoporosis: an update on pathogenesis and treatment. Canadian Family Physician. 1983;29(11):2113\u20132118.", "ArticleIdList": ["PMC2154301", "21283471"]}, {"Citation": "Iqbal M. M. Osteoporosis: epidemiology, diagnosis, and treatment. Southern Medical Journal. 2000;93(1):2\u201318.", "ArticleIdList": ["10653058"]}, {"Citation": "Riggs B. L., Khosla S., Melton L. J., III A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. Journal of Bone and Mineral Research. 1998;13(5):763\u2013773. doi: 10.1359/jbmr.1998.13.5.763.", "ArticleIdList": ["10.1359/jbmr.1998.13.5.763", "9610739"]}, {"Citation": "Manolagas S. C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews. 2000;21(2):115\u2013137. doi: 10.1210/edrv.21.2.0395.", "ArticleIdList": ["10.1210/edrv.21.2.0395", "10782361"]}, {"Citation": "Nagy V., Penninger J. M. The RANKL-RANK story. Gerontology. 2015;61(6):534\u2013542. doi: 10.1159/000371845.", "ArticleIdList": ["10.1159/000371845", "25720990"]}, {"Citation": "Teitelbaum S. L. Bone resorption by osteoclasts. Science. 2000;289(5484):1504\u20131508. doi: 10.1126/science.289.5484.1504.", "ArticleIdList": ["10.1126/science.289.5484.1504", "10968780"]}, {"Citation": "Takayanagi H., Ogasawara K., Hida S., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000;408(6812):600\u2013605. doi: 10.1038/35046102.", "ArticleIdList": ["10.1038/35046102", "11117749"]}, {"Citation": "Kim J. H., Kim N. Regulation of NFATc1 in osteoclast differentiation. Journal of Bone Metabolism. 2014;21(4):233\u2013241. doi: 10.11005/jbm.2014.21.4.233.", "ArticleIdList": ["10.11005/jbm.2014.21.4.233", "PMC4255043", "25489571"]}, {"Citation": "Boonen S., Rosenberg E., Claessens F., Vanderschueren D., Papapoulos S. Inhibition of cathepsin K for treatment of osteoporosis. Current Osteoporosis Reports. 2012;10(1):73\u201379. doi: 10.1007/s11914-011-0085-9.", "ArticleIdList": ["10.1007/s11914-011-0085-9", "22228398"]}, {"Citation": "Marsden J. The menopause, hormone replacement therapy and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 2002;83(1\u20135):123\u2013132. doi: 10.1016/S0960-0760(02)00258-3.", "ArticleIdList": ["10.1016/S0960-0760(02)00258-3", "12650709"]}, {"Citation": "Wu Y. X., Wu T. Y., Xu B. B., et al. Protocatechuic acid inhibits osteoclast differentiation and stimulates apoptosis in mature osteoclasts. Biomedicine & Pharmacotherapy. 2016;82(8):399\u2013405. doi: 10.1016/j.biopha.2016.05.008.", "ArticleIdList": ["10.1016/j.biopha.2016.05.008", "27470378"]}, {"Citation": "Rivera-Piza A., An Y. J., Kim D. K., et al. Protocatechuic acid enhances osteogenesis, but inhibits adipogenesis in C3H10T1/2 and 3T3-L1 cells. Journal of Medicinal Food. 2017;20(3):309\u2013319. doi: 10.1089/jmf.2016.3833.", "ArticleIdList": ["10.1089/jmf.2016.3833", "28296593"]}, {"Citation": "Xu G., Pei Q. Y., Ju C. G., Zhang F., Jia T. Z. Detection on effect of different processed Cibotium barometz on osteoblasts by CCK-8. Zhongguo Zhong Yao Za Zhi. 2013;38(24):4319\u20134323.", "ArticleIdList": ["24791538"]}, {"Citation": "Park S. H., Kim J. Y., Cheon Y. H., et al. Protocatechuic acid attenuates osteoclastogenesis by downregulating JNK/c-Fos/NFATc1 signaling and prevents inflammatory bone loss in mice. Phytotherapy Research. 2016;30(4):604\u2013612. doi: 10.1002/ptr.5565.", "ArticleIdList": ["10.1002/ptr.5565", "26792397"]}, {"Citation": "Jung Koo H., Sohn E. H., Kim Y. J., Jang S. A., Namkoong S., Chan Kang S. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. Journal of Ethnopharmacology. 2014;151(2):951\u2013959. doi: 10.1016/j.jep.2013.12.008.", "ArticleIdList": ["10.1016/j.jep.2013.12.008", "24333364"]}, {"Citation": "Henriksen S. S., Ding M., Vinther Juhl M., Theilgaard N., Overgaard S. Mechanical strength of ceramic scaffolds reinforced with biopolymers is comparable to that of human bone. Journal of Materials Science: Materials in Medicine. 2011;22(5):1111\u20131118. doi: 10.1007/s10856-011-4290-y.", "ArticleIdList": ["10.1007/s10856-011-4290-y", "21431906"]}, {"Citation": "Brandi M. L. Microarchitecture, the key to bone quality. Rheumatology. 2009;48(Supplement 4):iv3\u2013iv8. doi: 10.1093/rheumatology/kep273.", "ArticleIdList": ["10.1093/rheumatology/kep273", "19783591"]}, {"Citation": "Yang Y., Pan F., Wu F., et al. Familial resemblance in trabecular and cortical volumetric bone mineral density and bone microarchitecture as measured by HRpQCT. Bone. 2018;110(5):76\u201383. doi: 10.1016/j.bone.2018.01.033.", "ArticleIdList": ["10.1016/j.bone.2018.01.033", "29382612"]}, {"Citation": "Sakai A., Nishida S., Okimoto N., et al. Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice. Bone. 1998;23(5):443\u2013451. doi: 10.1016/S8756-3282(98)00121-5.", "ArticleIdList": ["10.1016/S8756-3282(98)00121-5", "9823451"]}, {"Citation": "Hong J., Stubbins R. E., Smith R. R., Harvey A. E., N\u00fa\u00f1ez N. P. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutrition Journal. 2009;8(1):p. 11. doi: 10.1186/1475-2891-8-11.", "ArticleIdList": ["10.1186/1475-2891-8-11", "PMC2650703", "19220919"]}, {"Citation": "Nilsson S., M\u00e4kel\u00e4 S., Treuter E., et al. Mechanisms of estrogen action. Physiological Reviews. 2001;81(4):1535\u20131565. doi: 10.1152/physrev.2001.81.4.1535.", "ArticleIdList": ["10.1152/physrev.2001.81.4.1535", "11581496"]}, {"Citation": "Kataoka T., Tamura M., Maeno A., Wakana S., Shiroishi T. Genetic dissection of trabecular bone structure with mouse intersubspecific consomic strains. G3: Genes, Genomes, Genetics. 2017;7(10):3449\u20133457. doi: 10.1534/g3.117.300213.", "ArticleIdList": ["10.1534/g3.117.300213", "PMC5633393", "28855285"]}, {"Citation": "Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142(12):5050\u20135055. doi: 10.1210/endo.142.12.8536.", "ArticleIdList": ["10.1210/endo.142.12.8536", "11713196"]}, {"Citation": "Boyle W. J., Simonet W. S., Lacey D. L. Osteoclast differentiation and activation. Nature. 2003;423(6937):337\u2013342. doi: 10.1038/nature01658.", "ArticleIdList": ["10.1038/nature01658", "12748652"]}, {"Citation": "Burgess T. L., Qian Y., Kaufman S., et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. The Journal of Cell Biology. 1999;145(3):527\u2013538. doi: 10.1083/jcb.145.3.527.", "ArticleIdList": ["10.1083/jcb.145.3.527", "PMC2185088", "10225954"]}, {"Citation": "Zhao Q., Shao J., Chen W., Li Y.-P. Osteoclast differentiation and gene regulation. Frontiers in Bioscience. 2007;12(1):2519\u20132529. doi: 10.2741/2252.", "ArticleIdList": ["10.2741/2252", "17127260"]}, {"Citation": "Zhao Q., Wang X., Liu Y., He A., Jia R. NFATc1: functions in osteoclasts. The International Journal of Biochemistry & Cell Biology. 2010;42(5):576\u2013579. doi: 10.1016/j.biocel.2009.12.018.", "ArticleIdList": ["10.1016/j.biocel.2009.12.018", "20035895"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "25"}, {"Year": "2018", "Month": "6", "Day": "27"}, {"Year": "2018", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["30151073", "PMC6087589", "10.1155/2018/7280342"]}}]}